|
|
|
Insider
Information: |
Vaishnaw Akshay |
Relationship: |
President |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
22,774 |
|
Indirect Shares
|
515 |
|
|
Direct
Value |
$3,400,158 |
|
|
Indirect Value
|
$76,890 |
|
|
Total
Shares |
23,289 |
|
|
Total
Value |
$3,477,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-26.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2023-08-04 |
22,774 |
2023-08-04 |
515 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-12-16 |
4 |
OE |
$7.10 |
$93,022 |
D/D |
10,626 |
10,626 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-03-17 |
4 |
OE |
$7.10 |
$75,875 |
D/D |
8,750 |
8,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-06-16 |
4 |
OE |
$7.10 |
$75,875 |
D/D |
8,750 |
8,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-11-25 |
4 |
OE |
$16.43 |
$99,750 |
D/D |
5,750 |
5,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2016-11-30 |
4 |
OE |
$22.75 |
$663,504 |
D/D |
29,165 |
34,915 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2016-12-30 |
4 |
OE |
$16.43 |
$187,251 |
D/D |
9,547 |
15,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, R&D |
|
2017-05-15 |
4 |
OE |
$21.35 |
$1,262,873 |
D/D |
43,750 |
21,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2017-05-23 |
4 |
OE |
$21.35 |
$234,850 |
D/D |
11,000 |
21,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2017-06-13 |
4 |
OE |
$18.66 |
$32,007 |
D/D |
1,668 |
11,965 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2017-10-30 |
4 |
OE |
$21.35 |
$718,769 |
D/D |
33,666 |
45,201 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2018-03-14 |
4 |
OE |
$7.10 |
$1,507,842 |
D/D |
88,554 |
99,769 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-02-07 |
4 |
OE |
$42.22 |
$960,505 |
D/D |
22,750 |
34,923 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-04-20 |
4 |
OE |
$42.22 |
$927,616 |
D/D |
21,971 |
36,090 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-06-22 |
4 |
OE |
$42.22 |
$40,953 |
D/D |
970 |
15,089 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2020-09-29 |
4 |
OE |
$42.22 |
$40,996 |
D/D |
971 |
15,090 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2021-06-18 |
4 |
OE |
$42.22 |
$723,495 |
D/D |
11,804 |
25,923 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2021-08-09 |
4 |
OE |
$63.00 |
$682,542 |
D/D |
10,834 |
22,049 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2022-12-05 |
4 |
OE |
$42.22 |
$299,938 |
D/D |
5,079 |
23,425 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2023-02-10 |
4 |
OE |
$63.00 |
$1,947,519 |
D/D |
30,913 |
53,014 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2023-04-27 |
4 |
S |
$193.18 |
$465,464 |
D/D |
(2,392) |
17,890 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2023-08-04 |
4 |
S |
$184.70 |
$753,986 |
D/D |
(4,057) |
22,774 |
0 |
% |
|
96 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|